Auriga Reiterates a 'Buy' on Impax Laboratories (IPXL); Positive After Meetin …StreetInsider.com (subscription)… nasals and implants); 2) Launch of IPX066 for Parkinson's; 3) Margin expansion and a lower tax rate driven by Taiwan manufacturing (several hundred bps); 4) New generic launches; 5) Positive Phase IIb data for IPX159, for Restless Leg Syndrome; … View full [...]
